Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.040 GeneticVariation disease BEFREE We identified significant aggregate-level associations between cognitive decline and the gene regions BIN1, CD33, CELF1, CR1, HLA cluster, and MEF2C in the all-female cohort and significant associations with ABCA7, HLA cluster, MS4A6E, PICALM, PTK2B, SLC24A4, and SORL1 in the all-male cohort. 27005436 2016
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.040 Biomarker disease BEFREE Our results suggest that CR1, ABCA7, and APOE correlate with specific aspects of cognitive impairments in AD patients. 24530172 2014
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.040 AlteredExpression disease BEFREE We found that ABCA7, CD33, and CR1 expression levels were associated with clinical dementia rating (CDR), with higher expression being associated with more advanced cognitive decline. 23226438 2012
CUI: C0002726
Disease: Amyloidosis
Amyloidosis
0.050 Biomarker disease BEFREE In consistence with human genetic studies, increasing evidence has demonstrated that ABCA7 deficiency exacerbates pathology using in vitro and in vivo models. 29401741 2018
CUI: C0002726
Disease: Amyloidosis
Amyloidosis
0.050 GeneticVariation disease BEFREE We investigated the association of Alzheimer's disease (AD)-related rare variants APP A673T and ABCA7 rs200538373-C with the levels of β-amyloid () and parameters of metabolic and cardiovascular health in a population-based cohort of healthy middle-aged and elderly men. 28556232 2017
CUI: C0002726
Disease: Amyloidosis
Amyloidosis
0.050 Biomarker disease BEFREE ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology. 27030769 2016
CUI: C0002726
Disease: Amyloidosis
Amyloidosis
0.050 GeneticVariation disease BEFREE High deposition was associated significantly with a lower Mini-Mental State Examination score (<27 points, p = 0.04), high systolic blood pressure (p = 0.04), carrying the apolipoprotein E epsilon 4 allele (p < 0.01), and lower plasma ApoE levels (p = 0.02), and variation in the ABCA7 (p = 0.02) and EPHA1 genes (p = 0.02). 24199960 2014
CUI: C0002726
Disease: Amyloidosis
Amyloidosis
0.050 Biomarker disease BEFREE Deletion of Abca7 increases cerebral amyloid-β accumulation in the J20 mouse model of Alzheimer's disease. 23467355 2013
CUI: C0014772
Disease: Red Blood Cell Count measurement
Red Blood Cell Count measurement
0.100 GeneticVariation phenotype GWASCAT Leveraging Polygenic Functional Enrichment to Improve GWAS Power. 30595370 2019
Red cell distribution width determination
0.100 GeneticVariation phenotype GWASCAT Leveraging Polygenic Functional Enrichment to Improve GWAS Power. 30595370 2019
RDW - Red blood cell distribution width result
0.100 GeneticVariation phenotype GWASCAT Leveraging Polygenic Functional Enrichment to Improve GWAS Power. 30595370 2019
Corpuscular Hemoglobin Concentration Mean
0.100 GeneticVariation phenotype GWASCAT Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases. 29403010 2018
CUI: C0200633
Disease: Neutrophil count (procedure)
Neutrophil count (procedure)
0.100 GeneticVariation phenotype GWASCAT The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease. 27863252 2016
CUI: C0200638
Disease: Eosinophil count procedure
Eosinophil count procedure
0.100 GeneticVariation phenotype GWASCAT The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease. 27863252 2016
CUI: C0200641
Disease: Blood basophil count (lab test)
Blood basophil count (lab test)
0.100 GeneticVariation phenotype GWASCAT The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease. 27863252 2016
CUI: C0162534
Disease: Prion Diseases
Prion Diseases
0.100 GeneticVariation group GWASDB Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP. 22210626 2012
CUI: C0003537
Disease: Aphasia
Aphasia
0.100 Biomarker disease HPO
CUI: C0004134
Disease: Ataxia
Ataxia
0.100 Biomarker phenotype HPO
CUI: C0009676
Disease: Confusion
Confusion
0.100 Biomarker phenotype HPO
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 Biomarker disease HPO
CUI: C0018524
Disease: Hallucinations
Hallucinations
0.100 Biomarker disease HPO
CUI: C0023015
Disease: Language Disorders
Language Disorders
0.100 Biomarker group HPO
CUI: C0026826
Disease: Muscle Hypertonia
Muscle Hypertonia
0.100 Biomarker phenotype HPO
CUI: C0027066
Disease: Myoclonus
Myoclonus
0.100 Biomarker phenotype HPO
CUI: C0036572
Disease: Seizures
Seizures
0.100 Biomarker phenotype HPO